Found: 32
Select item for more details and to access through your institution.
Increased levels of anti-Encephalitozoon intestinalis antibodies in patients with colorectal cancer.
- Published in:
- PLoS Neglected Tropical Diseases, 2024, v. 18, n. 9, p. 1, doi. 10.1371/journal.pntd.0012459
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 1, p. 85, doi. 10.1007/s40261-016-0463-2
- By:
- Publication type:
- Article
Complete Response to Aflibercept-FOLFIRI in One Patient With Colorectal Cancer Refractory to Bevacizumab-FOLFOX: A Possible Autocrine Vascular Endothelial Growth Factor Receptor 2-Related Mechanism.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 2, p. 148, doi. 10.1093/nop/npaa074
- By:
- Publication type:
- Article
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 1, p. 49, doi. 10.1038/s41416-024-02687-7
- By:
- Publication type:
- Article
Real-World Experience of Efficacy and Safety of Trabectedin in Patients with Soft Tissue Sarcoma: A Bicentric Retrospective Analysis.
- Published in:
- Oncology, 2022, v. 100, n. 12, p. 633, doi. 10.1159/000527602
- By:
- Publication type:
- Article
Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 11, p. 3255, doi. 10.1007/s11136-020-02721-0
- By:
- Publication type:
- Article
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 11, p. 2260, doi. 10.1002/1878-0261.13173
- By:
- Publication type:
- Article
Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2401, doi. 10.1002/1878-0261.12972
- By:
- Publication type:
- Article
Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice.
- Published in:
- Clinical Medicine Insights: Oncology, 2016, n. 10, p. 59, doi. 10.4137/CMO.s38335
- By:
- Publication type:
- Article
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920975356
- By:
- Publication type:
- Article
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920975356
- By:
- Publication type:
- Article
Cholangiocarcinomes avancés : traitements systémiques en deuxième ligne à l'ère de la médecine personnalisée.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 1, p. 59, doi. 10.1684/hpg.2023.2707
- By:
- Publication type:
- Article
Traitements systémiques de première ligne des cancers avancés des voies biliaires.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 10, p. 1035, doi. 10.1684/hpg.2023.2684
- By:
- Publication type:
- Article
Prise en charge du carcinome épidermoïde avancé du canal anal.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 9, p. 873, doi. 10.1684/hpg.2020.2025
- By:
- Publication type:
- Article
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.
- Published in:
- BMC Gastroenterology, 2014, v. 14, n. 1, p. 143, doi. 10.1186/1471-230X-14-143
- By:
- Publication type:
- Article
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.763926
- By:
- Publication type:
- Article
Exposure‐response analysis of Raltitrexed assessing liver toxicity.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1327, doi. 10.1111/bcp.14519
- By:
- Publication type:
- Article
Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3190, doi. 10.3390/cancers15123190
- By:
- Publication type:
- Article
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2188, doi. 10.3390/cancers15072188
- By:
- Publication type:
- Article
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 3, p. 225, doi. 10.1007/s00280-023-04603-x
- By:
- Publication type:
- Article
Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 141, doi. 10.1007/s00280-014-2482-0
- By:
- Publication type:
- Article
Molecular description of ANGPT2 associated colorectal carcinoma.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 7, p. 2007, doi. 10.1002/ijc.32993
- By:
- Publication type:
- Article
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 11, p. 3112, doi. 10.1002/ijc.32620
- By:
- Publication type:
- Article
Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 10, p. 2325, doi. 10.1002/ijc.30367
- By:
- Publication type:
- Article
French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel versus gemcitabine alone as second-line treatment in metastatic pancreatic cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241259635
- By:
- Publication type:
- Article
The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-015-0148-y
- By:
- Publication type:
- Article
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2860-6
- By:
- Publication type:
- Article